Biotech News
Exagen Inc. to Participate in Third Quarter Investor Conferences
investors.exagen.com2026-05-06 15:13 EST
CARLSBAD, Calif. , Aug. 06, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, today announced that management will participate in the following upcoming investor conferences: Canaccord Genuity 45 th Annual Growth Conference Participation: